Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Tariffs, inflation, and labor shortages have been challenging to some businesses, but many are still optimistic looking ahead ...

Twist Bioscience Corporation (NASDAQ:TWST) is one of the best gene-editing stocks to buy according to hedge funds. On ...

Dr. Olin E. "Gene" Rhodes Jr. is the winner of the 2025 Fred C. Davison Distinguished Scientist Award. Citizens for Nuclear ...

Editas strengthened its balance sheet by raising $17.8 million through its ATM (at-the-market) offering in the third quarter ...

Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

UK and ASEAN Strengthen Collaboration on Responsible Engineering Biology for a Sustainable Bioeconomy Bangkok, 10 November 2025 - The United Kingdom ...

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

The unsung heroes of the lab and lecture hall have laid the groundwork for some of the most transformative technologies of ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...